End-of-day quote
Other stock markets
|
||
- USD | - |
07-10 | Jazz Pharmaceuticals plc Promotes Samantha Pearce to Chief Commercial Officer | CI |
07-09 | RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating | MT |
Chart calendar Jazz Pharmaceuticals, Inc.
Upcoming events on Jazz Pharmaceuticals, Inc.
Past events on Jazz Pharmaceuticals, Inc.
2024-06-12 10:40 | Goldman Sachs Global Healthcare Conference |
2024-06-06 14:00 | Jefferies Global Healthcare Conference |
2024-06-05 12:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 304 |
2024-06-05 11:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 283 |
2024-06-04 17:45 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 263 - Ora |
2024-06-04 17:30 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 259 - Ora |
2024-06-04 12:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 436 |
2024-06-04 12:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 434 |
2024-06-04 12:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 432 |
2024-06-04 11:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 437 |
2024-06-04 11:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 407 |
2024-06-03 14:30 | American Society of Clinical Oncology Meeting - Abstract No:8094 |
2024-06-03 12:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 254 |
2024-06-03 12:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 256 |
2024-06-03 12:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 264 |
2024-06-03 11:00 | American Academy of Sleep Medicine and the Sleep Research Society Meeting - Poster Number: 265 |
2024-06-03 10:00 | American Society of Clinical Oncology Meeting - Abstract No:6521 |
2024-06-02 10:00 | American Society of Clinical Oncology Meeting - Abstract No:TPS4629 |
2024-06-01 14:30 | American Society of Clinical Oncology Meeting - Abstract No:TPS11590 |
2024-06-01 14:30 | American Society of Clinical Oncology Meeting - Abstract No:11560 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 162 2 142 0.94% | 2 364 2 338 1.08% | 3 094 3 064 0.98% | 3 659 3 665 -0.15% | 3 834 3 832 0.06% | 4 052 |
EBITDA Million USD | Released Forecast Spread | 1 117 1 135 -1.53% | 918 949 -3.25% | 1 978 1 367 44.73% | 1 338 1 473 -9.16% | 1 681 1 739 -3.36% | 1 728 |
EBIT Million USD | Released Forecast Spread | 1 102 1 121 -1.73% | 899 934 -3.77% | 1 425 1 280 11.35% | 1 307 1 400 -6.63% | 1 650 1 682 -1.85% | 1 709 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 454 466 -2.41% | 275 280 -1.87% | -113 -158 28.52% | -373 47,8 -880.03% | 298 379 -21.44% | 412 |
Net income Million USD | Released Forecast Spread | 523 535 -2.17% | 239 269 -11.26% | -330 -135 -144.85% | -224 -66,2 -238.34% | 415 519 -20.02% | 425 |
EPS USD | Released Forecast Spread | 9,09 8,59 5.82% | 4,22 4,30 -1.86% | -5,52 -6,36 13.25% | -3,58 -1,84 -94.67% | 6,10 7,53 -18.97% | 5,89 |
Announcement Date | 25/02/20 | 23/02/21 | 01/03/22 | 01/03/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 814 854 -4.69% | 933 903 3.36% | 941 940 0.08% | 972 976 -0.38% | 893 898 -0.58% | 957 942 1.61% | 972 969 0.29% | 1 012 1 005 0.65% | 902 954 -5.48% | 1 005 | 1 044 | 1 095 | 997 | 1 047 |
EBITDA Million USD | Released Forecast Spread | 410 370 10.79% | 419 401 4.43% | 510 453 12.52% | 31,2 427 -92.69% | 405 434 -6.61% | 435 459 -5.16% | 422 458 -7.89% | 429 463 -7.31% | 345 390 -11.48% | 431 | 466 | 521 | ||
EBIT Million USD | Released Forecast Spread | 403 369 9.23% | 411 392 4.74% | 502 434 15.73% | 23,9 183 -86.99% | 397 416 -4.53% | 428 431 -0.82% | 414 452 -8.4% | 421 441 -4.62% | 317 389 -18.49% | 431 | 466 | 500 | 412 | 467 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6,33 -63,5 109.96% | 21,0 -61,4 134.2% | -60,1 72,6 -182.84% | -340 97,4 -449.16% | 55,1 76,4 -27.92% | 81,8 102 -19.94% | 99,5 126 -21.28% | 61,5 145 -57.44% | -1,60 73,4 -102.18% | 99,1 | 134 | 181 | 116 | 141 |
Net income Million USD | Released Forecast Spread | 1,65 -64,3 102.56% | 34,7 276 -87.44% | -19,6 152 -112.91% | -241 -73,6 -227.03% | 69,4 145 -52% | 104 133 -21.21% | 147 178 -17.61% | 94,2 183 -48.5% | -14,6 85,3 -117.15% | 108 | 154 | 150 | 118 | 143 |
EPS USD | Released Forecast Spread | 0,03 -0,04 175% | 0,55 2,44 -77.49% | -0,31 2,47 -112.55% | -3,82 -2,78 -37.56% | 1,04 2,07 -49.64% | 1,52 1,97 -22.94% | 2,14 2,29 -6.68% | 1,42 2,72 -47.85% | -0,23 1,07 -121.53% | 1,45 | 2,12 | 2,09 | 1,67 | 2,03 |
Announcement Date | 04/05/22 | 03/08/22 | 09/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 28/02/24 | 01/05/24 | - | - | - | - | - |
Past sector events for Jazz Pharmaceuticals, Inc.
- Stock Market
- Equities
- JAZZ Stock
- Stock
- Calendar Jazz Pharmaceuticals, Inc.